Skip to content

Evaluation of an Opioid Safety Toolkit

Evaluation of an Opioid Safety Toolkit: A randomised controlled trial comparing the effect of an co-designed opioid safety toolkit to an existing website on opioid safety behaviours in people who are prescribed opioids

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000176561
Acronym
Prescription Opioid Safety Toolkit (POST)
Enrollment
314
Registered
2024-02-23
Start date
2024-06-12
Completion date
2024-07-22
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Through a co-design study we have designed an online Prescription Opioid Safety Toolkit to increase consumers knowledge about opioid pain medicines and safety relating to their use. This study will test if the effect of the Toolkit on opioid safety knowledge and behaviours, and the acceptability of the Toolkit prior to a planned national dissemination campaign.

Interventions

The intervention condition is exposure to the online Prescription Opioid Safety Toolkit that has been co-designed for this trial. The Prescription Opioid Safety Toolkit will include interactive self-completed opioid outcome tools, videos and other information designed for consumers on safer opioid use, including information on naloxone. Participants randomised to the intervention arm will be emailed a link to the Toolkit and asked to engage with the online resource initially for 30-60 minutes be

The intervention condition is exposure to the online Prescription Opioid Safety Toolkit that has been co-designed for this trial. The Prescription Opioid Safety Toolkit will include interactive self-completed opioid outcome tools, videos and other information designed for consumers on safer opioid use, including information on naloxone. Participants randomised to the intervention arm will be emailed a link to the Toolkit and asked to engage with the online resource initially for 30-60 minutes before completing a brief (10 min) follow up survey at Time 1, and a further 20-min follow up survey 4 weeks later at Time 2. Participants will be advised that they may choose to spend longer on the website initially and can or return to the online materials at a later time. To monitor adherence, participants will be asked at Time 1 how long they initially spent viewing the online material, as well as confirming that the Toolkit has been accessed via the link provided and which elements of the Toolkit are accessed and/or completed.

Sponsors

Monash University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligible participants will be Australian adults aged at least 18 who have been prescribed opioids for non-cancer pain for at least two weeks, and have taken opioids in the past four weeks.

Exclusion criteria

Unable to provide voluntary informed consent

Outcome results

None listed

Source: ANZCTR · Data processed: Jul 3, 2026